EMAIL THIS PAGE TO A FRIEND

Peptides

Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling.


PMID 19463742

Abstract

The melanocortin system is crucial to regulation of energy homeostasis. The melanocortin receptor type 4 (MC4R) modulates insulin signaling via effects on c-Jun N-terminal kinase (JNK). The melanocortin agonist NDP-MSH dose-dependently inhibited JNK activity in HEK293 cells stably expressing the human MC4R; effects were reversed by melanocortin receptor antagonist. NDP-MSH time- and dose-dependently inhibited IRS-1(ser307) phosphorylation, effects also reversed by a specific melanocortin receptor antagonist. NDP-MSH augmented insulin-stimulated AKT phosphorylation in vitro. The melanocortin agonist melanotan II increased insulin-stimulated AKT phosphorylation in the rat hypothalamus in vivo. NDP-MSH increased insulin-stimulated glucose uptake in hypothalamic GT1-1 cells. The current study shows that the melanocortinergic system interacts with insulin signaling via novel effects on JNK activity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M8764
[Nle4, D-Phe7]-α-Melanocyte Stimulating Hormone trifluoroacetate salt, ≥95% (HPLC)
C78H111N21O19 · xC2HF3O2